Article Cited by others

CASE REVIEW

Abatacept in psoriatic arthritis: Case report and short review

Ursini Francesco, Naty Saverio, Russo Emilio, Grembiale Rosa Daniela

Year : 2013| Volume: 4| Issue : 5 | Page no: 29-32

   This article has been cited by
 
1 Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles (of the responders)
Gaetano Zizzo,Elisa Gremese,Gianfranco Ferraccioli
Immunotherapy. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
Piero Ruscitti,Francesco Ursini,Paola Cipriani,Vasiliki Liakouli,Francesco Carubbi,Onorina Berardicurti,Giovambattista De Sarro,Roberto Giacomelli,Masataka Kuwana
PLOS ONE. 2017; 12(7): e0181203
[Pubmed]  [Google Scholar] [DOI]
3 Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study
Francesco Ursini,Emilio Russo,Daniele Mauro,Ludovico Abenavoli,Giorgio Ammerata,Alfonso Serrao,Rosa Daniela Grembiale,Giovambattista De Sarro,Ignazio Olivieri,Salvatore Dćangelo
European Journal of Clinical Investigation. 2017; 47(10): 728
[Pubmed]  [Google Scholar] [DOI]
4 Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis
Piero Ruscitti,Francesco Ursini,Paola Cipriani,Francesco Ciccia,Vasiliki Liakouli,Francesco Carubbi,Giuliana Guggino,Onorina Berardicurti,Rosadaniela Grembiale,Giovanni Triolo,Giovambattista De Sarro,Roberto Giacomelli
Medicine. 2017; 96(34): e7896
[Pubmed]  [Google Scholar] [DOI]
5 Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same?
Laura C. Coates,Oliver FitzGerald,Philip S. Helliwell,Carle Paul
Seminars in Arthritis and Rheumatism. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety
Brian A. Baldo
Drug Safety. 2015; 38(5): 455
[Pubmed]  [Google Scholar] [DOI]
7 Paradoxical psoriasiform reactions to anti-TNFa drugs are associated with genetic polymorphisms in patients with psoriasis
T Cabaleiro,R Prieto-Pérez,R Navarro,G Solano,M Román,D Ochoa,F Abad-Santos,E Daudén
The Pharmacogenomics Journal. 2015;
[Pubmed]  [Google Scholar] [DOI]
8 Co-signaling molecules in psoriasis pathogenesis: Implications for targeted therapy
Xiran Lin,Tian Huang
Human Immunology. 2015; 76(2-3): 95
[Pubmed]  [Google Scholar] [DOI]
9 Psoriatic arthritis: latest treatments and their place in therapy
Eun Jin Kang,Arthur Kavanaugh
Therapeutic Advances in Chronic Disease. 2015; 6(4): 194
[Pubmed]  [Google Scholar] [DOI]
10 New treatments for inflammatory rheumatic disease
Carlo Selmi,Elena Generali,Marco Massarotti,Gerolamo Bianchi,Carlo A. Sciré
Immunologic Research. 2014;
[Pubmed]  [Google Scholar] [DOI]
11 Abatacept in Psoriatic Arthritis: A Review
Sowmya Varada
Psoriasis Forum. 2014; 20a(2): 60
[Pubmed]  [Google Scholar] [DOI]
12 Adalimumab/etanercept/infliximab
Reactions Weekly. 2014; 1485(1): 5
[Pubmed]  [Google Scholar] [DOI]
13 Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Sabrina Ceeraz,Elizabeth C Nowak,Christopher M Burns,Randolph J Noelle
Arthritis Research & Therapy. 2014; 16(5): 469
[Pubmed]  [Google Scholar] [DOI]

 

Read this article